Hamilton, L. C., Vojnovic, I., & Warner, T. D. (1999). A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.
Chicago ZitierstilHamilton, Lorna C., Ivana Vojnovic, und Timothy D. Warner. A771726, the Active Metabolite of Leflunomide, Directly Inhibits the Activity of Cyclo-oxygenase-2 in Vitro and in Vivo in a Substrate-sensitive Manner. 1999.
MLA ZitierstilHamilton, Lorna C., Ivana Vojnovic, und Timothy D. Warner. A771726, the Active Metabolite of Leflunomide, Directly Inhibits the Activity of Cyclo-oxygenase-2 in Vitro and in Vivo in a Substrate-sensitive Manner. 1999.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.